Email Alerts
News
Replace - Change - Announcement Of Appointment Of Independent Non-Executive Director
BackNov 01, 2022
| Announcement Title | Change - Announcement of Appointment |
| Date & Time of Broadcast | Nov 1, 2022 12:21 |
| Status | Replace |
| Announcement Sub Title | Announcement of Appointment of Independent Non-Executive Director |
| Announcement Reference | SG221101OTHRS79H |
| Submitted By (Co./ Ind. Name) | Adrian Chui |
| Designation | CEO & Executive Director |
| Description (Please provide a detailed description of the event in the box below) | The checkbox for 'Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))' should be 'Yes' instead of 'No'. Please refer to the attached announcement. |
| Additional Details | |
| Date Of Appointment | 01/11/2022 |
| Name Of Person | Julie Lo Lai Wan |
| Age | 61 |
| Country Of Principal Residence | Singapore |
| The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process) | The Board of ESR-LOGOS Funds Management (S) Limited ( "E-LOG FM" ) had reviewed Dr Lo's qualifications and work experience and supported her appointment as Independent Non-Executive Director of E-LOG FM on the basis that she adds diversity of analysis, thoughts, views, advice and network to the Board of Directors and Management. Her extensive legal experience in the public healthcare sector which covers procurement, research, medical malpractice and collaborations with Singapore and global companies including within the National Healthcare Group will greatly provide alternate viewpoints from a commercial sensibility, risk, business process and corporate governance perspective. |
| Whether appointment is executive, and if so, the area of responsibility | Not applicable |
| Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | Independent Non-Executive Director |
| Professional qualifications | - Admitted to practise law in Singapore (Singapore Institute of Legal Education/ Singapore Bar) (Year conferred - 1990) - Admitted to practise law in New York (New York Bar) (Year conferred - 1988) - Admitted to practise law in England & Wales (The Honorable Society of Inner Temple) (Year conferred - 1986) |
| Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries | Nil |
| Conflict of interests (including any competing business) | Nil |
| Working experience and occupation(s) during the past 10 years | Dr Lo has been the Head of Group Legal Office of National Healthcare Group (NHG) since September 2020. NHG is a large healthcare company wholly-owned by the MOH Holdings Pte Ltd, Singapore, and comprises numerous hospitals, specialty centres and polyclinics. The Group Legal Office actively supports NHG's extensive business such as procurement, research, medical malpractice, corporate and commercial contracts, technology innovation and collaborations with Singapore and global companies. Dr Lo is a member of the NHG Domain Specific Review Board which is an independent committee that reviews and approves research studies. Dr Lo also actively participates in national initiatives and strategies including major reforms of the healthcare sector. Dr Lo was the Legal Director (Head of Legal & Contract Management Department) of Integrated Health Information Systems (IHiS) from June 2012 to December 2019 and was also Head of Procurement from 2012 to 2017. IHiS is the technology agency for Singapore's public healthcare sector and is wholly-owned by the MOH Holdings Pte Ltd, Singapore. Dr Lo built the Legal and Procurement Departments, guided IHiS through the Committee of Inquiry investigation into the SingHealth cyber attack in 2018 and led IHiS through several major public healthcare projects. Dr Lo was also the Company Secretary for IHiS. |
| Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6)) | Yes |
| Shareholding interest in the listed issuer and its subsidiaries? | No |
| # These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8). | |
| Past (for the last 5 years) | Integrated Health Information Systems - Legal Director (Head of Legal & Contract Management Department) |
| Present | National Healthcare Group - General Counsel |
| (a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? | No |
| (b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? | No |
| (c) Whether there is any unsatisfied judgment against him? | No |
| (d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? | No |
| (e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? | No |
| (f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? | No |
| (g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? | No |
| (h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? | No |
| (i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? | No |
| (j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :- | |
| (i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or | No |
| (ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or | No |
| (iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or | No |
| (iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? | No |
| (k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? | No |
| Any prior experience as a director of an issuer listed on the Exchange? | No |
| If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange | Pursuant to Rule 704(7)(a) of the Listing Manual, Dr Lo has no prior experience as a director of a listed company. Appropriate briefings and training will be provided in respect of roles and responsibilities of directors and corporate governance requirements. |
| Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable) | NA |